International Stem Cell Corporation Developed 3D Bioprinting Technology Targeted to Treat Liver Diseases – GlobeNewswire (press release)
|
International Stem Cell Corporation Developed 3D Bioprinting Technology Targeted to Treat Liver Diseases
GlobeNewswire (press release) CARLSBAD, Calif., Oct. 09, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company that develops novel stem … |
